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The effects of deafferentation and alterations of synaptic activ- 
ity on levels of a synaptic vesicle-specific membrane protein 
(SV) were studied in the adult rat superior cervical ganglion 
(SCG) in viva, using a monoclonal antibody directed against the 
protein. Levels of SV were quantified by radioimmunoassay. 
Deafferentation of the SCG results in a transient increase in 
SV levels in the SCG on days 7 and 10 after surgery, with levels 
then dropping below control levels on days 14, 21, and 30 after 
surgery. Immunohistochemical labeling of deafferented ganglia 
indicates that the increase is confined to the perikarya of prin- 
cipal ganglionic neurons. Levels of SV in an SCG target tissue, 
the iris, do not differ from control levels on day 7 after deaffer- 
entation, but are elevated at days 10, 14, and 30 after surgery. 
After reinnervation of the SCG, levels of SV in the SCG are 
elevated above control values, but do not differ from control 
values in the iris. Treatment with chlorisondamine, which blocks 
synaptic transmission in sympathetic ganglia, produces a sig- 
nificant increase in SV levels in the SCG after 7 d of treatment. 
Long-term chlorisondamine treatment results in reductions in 
SV in the SCG after 14 and 28 d. Treatment with phenoxy- 
benzamine for 6 d, which reflexly increases synaptic activity, 
produces a marked decrease in SV in the SCG. These results 
suggest that activity, mediated by transsynaptic factors, con- 
tributes to the regulation of synthesis of a synaptic vesicle pro- 
tein in the SCG. The results further suggest that accumulation 
of synaptic vesicles in terminals of the principal ganglion neu- 
rons may help regulate the maintenance of normal synaptic ves- 
icle pools within sympathetic neurons. 
While ample evidence for neural plasticity exists in the devel- 
oping nervous system, studies of responses in adult systems have 
in general shown considerable limitations in the ability to re- 
spond to and recover from alterations in connectivity and ac- 
tivity. Among peripheral systems, the adult rat superior cervical 
ganglion (SCG) is one in which several studies have documented 
plasticity in response to experimental manipulations. Deaffer- 
entation of the SCG by section of the cervical sympathetic trunk 
(CST) in adult animals has been reported to produce only limited 
changes in ganglion size in the absence of regeneration of the 
CST (Gabella, 1976). If the CST is permitted to reinnervate the 
SCG, recovery of normal numbers of synapses occurs, as as- 
sessed by morphometric analysis, and restoration of normal 
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levels of the neurotransmitter synthetic enzymes, choline ace- 
tyltransferase and tyrosine hydroxylase (T-OH) are observed 
(Gabella, 1976; Raisman et al., 1974). Thus, the SCG is ap- 
parently capable of functional recovery from deafferentation. In 
contrast to these studies, recent work has shown that the bio- 
chemical nature of the ganglion can be significantly altered by 
deafferentation or pharmacological alteration of neuronal activ- 
ity. Substance P (SP), which is present in very low levels in 
normally innervated ganglia, rises significantly after deafferen- 
tation, treatment with chlorisondamine, which blocks cholin- 
ergic transmission in the SCG, or removal to explant culture 
(Adler and Black, 1984; Kessler and Black, 1982; Kessler et al., 
1983). T-OH levels are increased by preganglionic electrical 
stimulation (Zigmond et al., 1980) and by treatment with re- 
serpine (Thoenen et al., 1969). 
The present study was undertaken in response to the obser- 
vation that 7 d after deafferentation, levels of a synaptic vesicle 
antigen increase significantly in the SCG, despite the degener- 
ation of presynaptic terminals within the ganglion (Greif, 1985). 
This observation stimulated the investigation of the regulation 
of numbers of synaptic vesicles in the adult rat SCG and in 
target tissue. Given that regeneration of the CST is possible, it 
is of interest to investigate whether the numbers of synaptic 
vesicles also recover to normal levels. In addition, since deaf- 
ferentation not only removes presynaptic input to the SCG but 
reduces synaptic transmission, the synthesis of synaptic vesicles 
may be influenced by activity-related transsynaptic factors. A 
monoclonal antibody directed against a 65 kDa integral mem- 
brane protein specific to synaptic vesicles (Matthew et al., 198 1) 
has been used to indirectly monitor changes in vesicle number. 
Previous studies with this antigen in the developing rat SCG 
showed that the antigen undergoes significant postnatal in- 
creases that are correlated with the time course of synapse for- 
mation within the SCG and the accumulation of vesicles within 
the cytoplasm of principal ganglion cells (Greif and Reichardt, 
1982). I sought to determine whether deafferentation or alter- 
ations of synaptic activity resulted in changes in levels of the 
vesicle antigen in the SCG and in the iris, and how such changes 
might be correlated. 
Materials and Methods 
Characterization of antigen 
Monoclonal antibodies (SV 48) directed against a 65 kDa integral mem- 
brane protein (SV) associated with the external surface of synaptic ves- 
icles of all neurotransmitter types investigated thus far (Floor and Lee- 
man, 1983; Matthew et al., 198 1; Pfeffer and Kelly, 1985) were obtained 
from Drs. L. F. Reichardt and W. D. Matthew. The antigen can be 
localized to both presynaptic terminals and principal cell cytoplasm in 
the SCG (Greif and Reichardt, 1982). The antibody is used to indirectly 
monitor numbers of synaptic vesicles by measuring antigen levels after 
different experimental manipulations. While no direct conversion be- 
tween SV levels and numbers of vesicles is possible at present, the 
approach has been used effectively in other systems (cf. Greif and Kelly, 
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1983; Greif and Reichardt, 1982; Matthew et al., 1981; Pfeffer and 
Kelly, 1985). 
Surgery 
Surgery on adult female Sprague-Dawley rats was carried out using 
chloral hydrate (35 mg/kg, 7% solution, i.p.) as general anesthetic. Deaf- 
ferentation of the SCG was carried out bv section of the CST 2-3 mm 
from the base of the ganglion. Rats were anesthesized, and the skin over 
the throat opened and lightly retracted. The SCG was visualized by 
blunt dissection down to the carotid artery, with the aid of a surgical 
dissecting microscope (Aus Jena). The CST was cut using jeweler’s 
forceps. In cases when reinnervation was not desired, a section of the 
CST was removed. To encourage reinnervation, the trunk was repeat- 
edly crushed with jeweler’s forceps, leaving a small fraction of the sheath 
intact. All surgery was carried out bilaterally to control for possible 
compensatory responses in the contralateral ganglion (cf. Domay et al., 
1985). The fascia and skin were sutured separately using 4-O silk. All 
animals were given prophylactic doses of Bicillin (100,000 units) to 
prevent respiratory infections. Mortality was less than 1% with anti- 
biotic treatment. Success of surgical procedures was assessed by the 
presence of marked ptosis following section of the CST. Animals were 
permitted to live for 4, 7, 10, 14, 2 1, or 30 d following deafferentation 
to determine the time course of changes in SV. For studies of reinner- 
vated ganglia, animals lived a minimum of 60 d after surgery. No ptosis 
was present in animals in which successful reinnervation had occurred 
by this time. At the time of death, careful visual inspection of the SCG 
was carried out to confirm the presence or absence of innervating fibers. 
Unoperated controls were aged-matched in all cases. Irides were dis- 
sected from experimental and control groups and processed in parallel 
to SCG samples. 
Implantation of osmotic pumps (Alza; flow rate, 2.5 pl/hr) was carried 
out under chloroform anesthesia. A small incision was made in the skin 
on the back and a subcutaneous pocket was prepared. The sterile, equil- 
ibrated pump was inserted and the incision was closed with wound 
clips. 
Drug treatment 
Blockade of ganglionic presynaptic activity was achieved using chlor- 
isondamine (Ecolid Chloride. CIBA: 10 mn/kg, s.c.) in physiological 
saline. Chlohsondamine competitively inhibits-the binding of ACh to 
postsynaptic receptors. Rats were injected every 12 hr for 7 d and 
immediately sacrificed. Synaptic blockade was confirmed by the pres- 
ence of ptosis (cf. Kessler and Black, 1982). For long-term blockade of 
synaptic activity, rats were implanted with osmotic pumps (Alza) which 
were filled with a 5 mg/ml solution of chlorisondamine in Ringer’s 
solution. This dose, selected in pilot studies to produce ptosis but permit 
long-term survival, was equivalent to an injected dose of 1.2 mg/kg/d. 
Mortality was 20% for 28 d survival. At higher doses, mortality rates 
were excessively high (>50%). Control animals were implanted with 
pumps containing vehicle. All control animals survived for 28 d. For 
reflex increases in synaptic activity, the alpha-adrenergic blocker phen- 
oxybenzamine (SK&F 688-A; 15 mg/kg, i.p.) in DMSO was injected 
twice daily for 6 d. The experiment was terminated 1 d early because 
of excessive drug toxicity. Control animals were treated with injections 
of vehicle. 
Quantitation of antigen levels 
The assay employed is a measure of the amount of whole tissue ho- 
mogenate required to inhibit 50% of antibody binding in a standard 
solid-phase radioimmunoassay (RIA) (Greifand Reichardt, 1982). Gan- 
glia from 4-6 adult rats were pooled to provide sufficient tissue for assay 
of each experimental condition at least twice. Tissue was homogenized 
in a lysis buffer of 5 mM Tris, pH 8.1, with the protease inhibitor 
phenyl methyl sulfonylfluoride (PMSF) added. After 30 min incubation 
at 4”C, tissue samples were stored in PBS and 10% sucrose. Protein 
determinations were by Amido-Schwarz assay, using BSA as a standard. 
Tissue samples were adjusted to 2-4 mg/ml initial protein concentration 
prior to preparation of a dilution series over 4 log units. Samples of 
each tissue dilution were incubated with aliquots of monoclonal anti- 
body at a dilution selected to be limiting in the solid-phase RIA (Klin- 
man, 1972). Bound antibody was precipitated by spins at 100,000 x g 
in an Airfuge. Antibody remaining in the supematant was assayed by 
solid-phase RIA, using crude rat brain synaptosomes as the antigen 
(Jones and Matus, 1974); 50% inhibition points (I-50) were determined 
graphically and standardized to an initial protein concentration of 4 
mg/ml. Additional corrections for differences in ganglionic protein con- 
tent were calculated according to (I-50 experimental) x [control ganglion 
(mg protein)/experimental ganglion (mg protein)]. For assay of target 
tissue, irides from experimental and control animals were processed 
similarly. 
Localization of antigen 
Ganglia to be used for immunohistochemistry were removed, de- 
sheathed, and immediately mounted on cryostat chucks using Tissue- 
Tek. At least 2 ganglia from different animals in each experimental 
condition were used. Samples were frozen with dichlorodifluorometh- 
ane (Histofreeze). Frozen unfixed sections of SCG, 8 pm thick, were cut 
and either used immediately or stored desiccated at -80°C. Affinity- 
purified HRP-conjugated anti-mouse immunoglobulin antisera (Sigma) 
were preabsorbed with rat liver acetone powders. Sections were incu- 
bated with blocking serum for 1 hr, then overnight with SV 48 at 4”c, 
followed by washing with PBS-BSA (1 mg/ml). Sections were then 
incubated with HRP-conjugated second antibodies for 2-4 hr at room 
temperature. Following final washes in PBS, label was visualized using 
3,3’-diaminobenzidine and 0.01% H,O, in 50 mM Tris, pH 7.6, for 15- 
30 min. Sections were mounted in 60% glycerol in PBS and viewed 
using a Zeiss Universal microscope equipped with Nomarski optics. 
Experimental and control tissues were processed in parallel for im- 
munocytochemistry. Controls included replacement of primary anti- 
body with BSA or normal mouse serum. Higher backgrounds were 
consistently observed using normal serum. 
Results 
Deafferentation of adult SCG produced, on average, a 24% re- 
duction in total protein content per ganglion (control SCG: 84.4 + 
2.5 rg protein per ganglion; deafferented SCG: 64.1 + 6.4 pg). 
This reduction was observed in samples beginning on day 7 
after surgery. No reduction in protein content was observed in 
ganglia taken 4 d after surgery. No significant changes in protein 
content in the iris were observed following deafferentation of 
the SCG (iris: 39.6 f 1.1 Mug protein). Treatment with chlori- 
sondamine, phenoxybenzamine, saline, and DMSO did not sig- 
nificantly alter protein content of either the SCG or iris. 
Adult rats were killed 4, 7, 10, 14, 21, and 30 d after section 
of the CST to determine the time course of changes in SV levels 
within the ganglion. The results of assays of SV in SCG tissue 
samples at varying times after bilateral deafferentation of the 
SCG are shown in Figure 1. Data are presented as the relative 
specific activity (R.S.A.) of experimental groups as compared 
to control tissue. I-50 levels were normalized for ganglionic 
protein content to permit direct comparison of experimental 
and control tissues. An equal SV content would be expressed 
as a R.S.A. value of 1 .O. Four days after deafferentation, levels 
of SV do not differ from control values. However, by day 7, SV 
levels are 1.5 1 times greater than control values (t test; p < 
0.005) and elevated SV levels persist at day 10 (R.S.A. = 1.46). 
This increase in SV level is transient, with values dropping to 
0.68 of control values by 14 d after surgery, 0.59 by 21 d, and 
0.40 by 30 d (t tests; p < 0.05). Levels of SV in the reinnervated 
SCG are elevated at 1.35 (t test; p < 0.025). 
Increases in SV levels observed in the SCG are not the result 
of nonspecific interactions between SV 48 and ganglionic tissue, 
since RIA of other neuron-specific antigens indicates no signif- 
icant alterations in antigen levels (Table 1; cf. Greif and Tren- 
chard, 1984). 
Histological analysis of sections of SCG stained for SV reveals 
that most punctate terminal stain associated with presynaptic 
terminals (Fig. 2A) (cf. Greif and Reichardt, 1982) has disap- 
peared by 7 d after deafferentation, suggesting that the increase 
in SV levels cannot be due to the persistence of antigen in 
presynaptic terminals (Fig. 2B). No evidence for punctate ter- 
minal labeling can be observed in sections from 30 d deaffer- 
ented ganglia (Fig. 2C). At the same time, the perikarya of the 
principal ganglionic neurons are heavily labeled. These obser- 
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Figure 1. Time course of changes in 
SV in the SCG after bilateral deaffer- 
entation of adult rat SCG. Surgery was 
carried out on day 0, with rats killed 
on the days indicated. R.S.A. = I-50 
experimental/I-50 aged-matched 
controls. 1-50s were normalized for 
ganglionic protein content. Bars, 1 
SEM. Numbers in parentheses indi- 
cate numbers of assays. A significant 
increase in SV is observed in deaffer- 
ented SCG on days 7 and 10 after 
2.0 
1.5 
4 
05 1.0 
ti 
0.5 
Q (3) 
surgery. SV is significantly less than 
control values at 14, 21, and 30 d 
I I 1 I 
after surgery. Open square, the rein- 
nervated SCG (>60 d after surgery). 4 
R.S.A. is significantly greater than 
control values. See text for details. 
vations strongly suggest that increases in SV levels within the 
deafferented SCG must occur within the principal ganglion neu- 
rons. No histological evidence for SV accumulation or produc- 
tion in other cell types of the SCG was obtained. Immunocy- 
tochemical labeling of sections of reinnervated SCG shows the 
reappearance of punctate terminal staining between the prin- 
cipal ganglionic neuron perikarya (Fig. 20). 
Assays of SV levels in the iris, a primary target of the SCG, 
were carried out in order to determine whether the increases in 
SV observed in the SCG following deafferentation might be the 
result of blocked axoplasmic transport. If this were the case, 
decreased levels of transported SV might be observed in target 
tissue. Results of assays of SV in iris are shown in Figure 3. SV 
levels in the iris 4 and 7 d after deafferentation of the SCG do 
not differ significantly from control values (t test; p > 0.10). 
However, at longer survival times, levels of SV in iris were 
significantly increased above control levels, beginning at day 10 
after surgery (R.S.A. = 1.56, t test; p < 0.05) and remaining 
elevated at 1.63 and 1.42 times control values at 14 and 30 d, 
respectively (t tests; p < 0.05). A small increase in SV in the 
iris was observed at 2 1 d (R.S.A. = 1. lo), but was not statistically 
significant. These findings suggest that the increase observed in 
SV in the SCG at 7 d cannot be the result of altered axoplasmic 
transport. 
The increase in SV levels 7 d after deafferentation can also 
be produced by 7 d of treatment with chlorisondamine, which 
blocks cholinergic synaptic transmission in the SCG. As is shown 
in Figure 4, treatment with chlorisondamine for 7 d results in 
an R.S.A. of 1.89 (t test; p < 0.005). This increase occurs in 
the presence of an intact CST, which suggests that activity plays 
a critical role in mediating the increase in SV. Immunohisto- 
chemical staining of sections of the SCG yields results that do 
Table 1. RIA of neuronal antigens in 7 d deafferented SCG 
Antibody Antigen RSA (+ 1 SEM) 
48 sv 1.51 k 0.06* 
22 HeS-PG (core protein) 1.18 + 0.06** 
3a HeS-PG (side chain) 0.83 + 0.10** 
0 Data taken from Greif and Trenchard (1984). 
*p < 0.005. 
**p > 0.10. 
Days after surgery 
not differ markedly from those of control ganglia (data not 
shown). Longer-term treatment with chlorisondamine yields re- 
sults similar to that observed with longer survival periods after 
deafferentation. Levels of SV in the SCG drop to 0.98 times 
control values after 14 d of treatment, and to 0.62 times control 
after 28 d. Treatment with phenoxybenzamine, which increases 
synaptic activity, produces a marked reduction in SV in the 
SCG (R.S.A. = 0.50, t test; p < 0.05). No significant differences 
between vehicle-treated and normal adult rat SCGs were ob- 
served. 
Treatment with chlorisondamine for 7 d leads to an increase 
in SV levels in the iris, but this increase is not statistically 
significant (t test; p > 0.10) (Fig. 4). However, long-term chlor- 
isondamine treatment results in significant increases in SV con- 
tent in the iris (t tests; p < 0.05). Treatment with phenoxyben- 
zamine for 6 d produces a significant decrease in SV levels in 
the iris (R.S.A. = 0.44, t test; p < 0.025). When reinnervation 
of the SCG is permitted, levels of SV in the iris return to control 
values, suggesting that alterations in levels of SV in a SCG target 
may also be the result of altered activity levels within the gan- 
glion. 
Discussion 
The results from assays of deafferented SCGs from adult rats 
indicate that levels of SV undergo rapid changes following sur- 
gery. A significant increase in SV levels was observed 7 d after 
section of the CST, followed by a fairly rapid decline in antigen 
level. The present study has not resolved finely the time course 
ofchanges in antigen levels; nevertheless, the apparent induction 
in SV occurs within 7 d after surgery. The pattern of changes is 
unexpected; it is reasonable to predict that levels of a synaptic 
vesicle antigen would drop with the degeneration of presynaptic 
terminals. This is indeed the case for Synapsin 1, a synaptic 
vesicle-specific phosphoprotein, where the existence of a pool 
of approximately 40% of total SCG Synapsin 1 was demon- 
strated in neuronal perikarya l-4 weeks after removal of pre- 
ganglionic input in the rabbit SCG (Nestler and Greengard, 
1982). This finding is in agreement with the results of the present 
study, where 40% of control levels of SV in the SCG were 
observed 30 d following deafferentation, which suggests that 
Nestler and Greengard (1982) studied antigen levels after the 
transient peak reported in the present study. Alternatively, the 
rabbit may not exhibit the same plasticity as the rat. The increase 
in SV levels is consistent with a report of increased immuno- 
The Journal of Neuroscience Synaptic Vesicle Plasticity in Adult Rat SCG 3631 
Figure 2. Immunohistochemical labeling of SCG with SV 48. Distribution of SV in 8 Frn frozen sections of unfixed SCG was visualized using 
HRP-conjugated second antibodies. Nomarski optics. 1250 x . A, Unoperated SCG (control). Heavy staining of principal ganglion neuron cytoplasm 
and staining of presynaptic terminals (arrows) between cell bodies is shown. B, Deafferented SCG 7 d after surgery. Most punctate terminal stain 
has disappeared. Heavy staining of cell cytoplasm is present. C, Deafferented SCG 30 d after surgery. No evidence for punctate terminal stain is 
present. In addition, there is a suggestion of some loss of label from cell bodies. 0, Reinnervated SCG 70 d after surgery. Punctate terminal stain 
has reappeared (arrows). See text for discussion. 
fluorescence labeling in deafferented SCG, using a polyclonal 
antisera directed against synaptic vesicles (Hooper et al., 1980). 
However, the investigators did not specify the time after deaf- 
ferentation that sections were prepared. 
The increase in SV levels following deafferentation must be 
the result of an accumulation of SV in neuronal cell perikarya, 
since immunohistochemical labeling of SV in deafferented gan- 
glia confirms the disappearance of punctate staining associated 
with presynaptic terminals (cf. Greif and Reichardt, 1982). 
Staining of non-neuronal cells in the SCG was not observed 
following deafferentation. The increase in SV within cell bodies 
is not visible in histological sections, probably as a result of the 
limited quantitative sensitivity of the method. 
What factors might contribute to the increase in SV in the 
SCG after deafferentation? One immediate concern is that deaf- 
ferentation leads to blocked or slowed axoplasmic transport of 
SV to terminals in target tissue. If this were the case, SV would 
accumulate in the SCG and levels of SV might be expected to 
drop in targets, even in the absence of neuronal activity, because 
of protein turnover. Although the turnover rate of SV is not 
known, the present results argue against blocked axoplasmic 
transport as the mechanism responsible for the observed in- 
crease of ganglionic SV. Assay of SV levels in the iris after 
deafferentation did not reveal any decrease in antigen; SV levels 
showed a tendency to increase in target tissue with longer sur- 
vival times. Given that this is the case, it seems likely that the 
increase in SV levels represents new synthesis of SV by gangli- 
onic neurons. Studies of the role of new protein synthesis in 
mediating SV increases are anticipated. 
Deafferentation of the SCG results in the cessation of normal 
synaptic activity within the SCG. If levels of activity are either 
directly or indirectly regulating ganglionic SV levels, then agents 
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Figure 3. Time course of changes in 
SV in iris after deafferentation of the 
SCG. Data presented as in Figure 1. 
No differences in SV levels are ob- 
served 4 and 7 d after surgery. SV 
levels in iris at IO, 14, and 30 days 
after surgery are significantly above 
control values. Open square repre- 
sents iris in reinnervated SCG ani- 
mals. SV levels do not differ from 
control levels. See text for discussion. 
0.5 - 
/I I I 1 1 1 1 , 
4 7 IO 14 21 30 Reinn 
Days after surgery 
that alter synaptic activity might be expected also to produce 
changes in SV levels. Treatment of rats with the ganglionic 
blocking agent, chlorisondamine, for 7 d produces an increase 
in SV levels within the SCG. It is possible that a portion of this 
increase is due to changes in SV levels in intact presynaptic 
terminals. However, because of the similarities in response to 
deafferentation and ganglionic blockade, it is likely that signif- 
icant changes are occurring in principal ganglionic neurons. 
Longer term ganglionic blockade results in reductions in SV in 
the SCG, similar to those observed following deafferentation. 
Treatment with phenoxybenzamine, which reflexly increases 
presynaptic activity (cf. Kessler and Black, 1982) produces a 
marked decrease in SV levels in both SCG and iris. It is not 
possible on the basis of this study to determine whether altered 
levels of SV are confined to cell cytoplasm or also occur in 
presynaptic terminals. 
The above findings are consistent with the hypothesis that 
Figure 4. Effects of pharmacological 
treatments on SV levels in SCG and 
iris. Rats were treated with chlorison- 
damine (10 mg/kg, s.c.; dark shading) 
for 7 d, or with phenoxybenzamine 
(15 mg/kg, i.p.; light hatching) for 6 
d (P6). Treatment with chlorisonda- 
mine for 14 and 28 d (medium and 
light shading) was via osmotic pumps 
(equivalent dose, 1.2 mg/kg/d). White 
bars are pooled control (vehicle-in- 
jected) animals. Data presented as in 
Figure 1, with control values stan- 
dardized to a value of 1 .O. Treatment 
with chlorisondamine significantly 
increases SV levels in the SCG at 7 d. 
The increase in iris is not statistically 
significant. Levels of SV in SCG after 
28 dare significantly less than control 
values. Increases in iris at both 14 and 
28 d are significant. Treatment with 
phenoxybenzamine significantly de- 
creases SV levels in both SCG and 
iris. See text for further discussion. 
1.0 
0.s 
i--i 
activity plays a critical role in regulating expression of neuronal 
proteins. At present, it is not possible to rule out the possibility 
that other factors, such as those produced by degenerating nerve 
terminals, may contribute to the induction of SV after deaffer- 
entation. The results of long-term treatment with chlorisonda- 
mine suggest that altered activity plays the primary role in reg- 
ulating SV levels after deafferentation. 
Previous studies have demonstrated that deafferentation of 
adult ganglia blocks the normal induction of T-OH in the SCG 
following catecholamine depletion produced by treatment with 
reserpine (Komack et al., 1985; Raisman et al., 1974; Thoenen 
et al., 1969). T-OH levels also increase following preganglionic 
nerve stimulation (Zigmond et al., 1980) consistent with in- 
creased release of catecholamines at ganglionic targets. Alter- 
ations in activity are known to induce changes in the expression 
of SP within the SCG (Kessler and Black, 1982; Kessler et al., 
198 1, 1983; Komack et al., 1985). Agents that decrease neuronal 
(2) 
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activity tend to increase synthesis of SP, stimulation of the SCG 
blocks these increases (cf. Kessler and Black, 1982; Kessler et 
al., 198 1, 1983). However, whether increased levels of SP persist 
after long-term deafferentation was not examined. Treatment 
with phenoxybenzamine, which increases ganglionic activity, 
produces a decrease in ganglionic SP. The induction of SP in 
vitro is blocked by treatment with depolarizing agents such as 
veratridine or K+, suggesting that neuronal depolarization is 
involved (Adler and Black, 1984). 
If reduced activity in the SCG plays a critical role in inducing 
increases in SV levels, what might contribute to the transient 
nature of the increase? Reinnervation studies indicate that SV 
levels are slightly elevated in the SCG after synaptic transmis- 
sion is reestablished. However, SV levels do not remain elevated 
after survival periods of 14, 2 1, or 30 d after deafferentation. 
In the present study, levels of SV in a primary target tissue, the 
iris, show a slow increase after deafferentation. Elevated levels 
of SV are observed in the iris 14 and 30 d after deafferentation, 
at the same time that SV levels decrease significantly below 
control levels in neuron perikarya. It is possible that the accu- 
mulation of SV in the inactive terminals of ganglionic neurons 
might regulate continuing synthesis of SV in the neuronal cell 
body. As long as SV levels remain high in terminals, synthesis 
of SV by the principal ganglionic neurons might remain de- 
pressed. Thus, “end-product” regulation of SV synthesis may 
contribute to the overall pattern of SV response after deaffer- 
entation. 
The results of the present study offer further evidence that 
considerable plasticity in response to changing neuronal envi- 
ronments exists in the sympathetic nervous system. The adult 
nervous system remains sensitive to alterations in synaptic ac- 
tivity levels and responds rapidly to such changes. 
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